|Champions in Indian Healthcare Acknowledged at Frost & Sullivan's 4th Annual India Healthcare Excellence Awards 2012 |
Mumbai, India, September 22, 2012 – Frost & Sullivan’s much-anticipated 4th Annual India Healthcare Excellence Awards 2012, acknowledging champions of the industry, was held in Mumbai last evening. These coveted Awards recognized innovative growth strategies and solutions adopted by top companies in the healthcare industry for 2011-12. Over the years, these Awards have become an industry benchmark and are attended by the who’s who in the healthcare industry.
The Indian healthcare industry has been on a growth trajectory and is expected to grow at a compound annual growth rate (CAGR) of 10-12 percent over the next five years. Contributory factors include rise in population, Government health initiatives, medical tourism, growth in health insurance, increase in lifestyle diseases, high disposable incomes, and overall development in Tier II cities across India. These factors are also promoting new and innovative healthcare models like asset-light hospitals, day-care models, single specialties, low-cost hospitals, wellness, retail healthcare models, and innovations across pharma and medical technology space. It has become vital for healthcare companies and consumers to stay abreast of these innovative solutions and companies working to create them. Frost & Sullivan’s Healthcare Practice, through its Annual India Healthcare Excellence Awards, identifies, studies, and acknowledges relevant contributions of such companies.
This year, Frost & Sullivan honored Dr. Habil Khorakiwala, Chairman, Wockhardt Limited, with a special Lifetime Achievement Award. Dr. Khorakiwala has made an immense contribution toward transforming the Indian pharmaceutical and healthcare scenario. His pioneering spirit and vision led to establishment of the Wockhardt Group, which has burgeoned into India’s leading research-based global healthcare enterprise; with relevance in fields of pharmaceuticals, biotechnology, nutraceuticals, dermato-cosmeceuticals, cardiology, along with establishment of a chain of advanced super speciality hospitals.
Sandeep Sinha, Director, Healthcare & Life Sciences, Frost & Sullivan, South Asia & Middle East, stated, “In our annual Healthcare Awards, we utilize the opportunity to choose and recognize an individual whose singular contribution has made a positive impact not only on the industry, but also on society at large. While the Corporate Awards are identified by our team and ratified by an eminent panel, the Lifetime Achievement Award is conferred by Frost & Sullivan on thought leaders who have dedicated themselves toward addressing India’s pertinent healthcare challenges, making an indelible impact in this field.”
“This year, we have added new Award categories in Healthcare Delivery Services like Dental, Dialysis, and Healthcare Delivery across different Revenue Sizes. New categories in Medical Technology include Wound Management, Ophthalmic Implants, Sleep Solutions, and Sterilization Management. For Biotech and Pharma section, the new categories are Fastest-Growing Indian International Pharmaceutical Company, Fastest-Growing Indian Biotechnology Company, Doctors’ Choice Awards like Oncologist's Award for the Best Oncology Company, Diabetologist's Award for the Best Diabetology Company, and Paediatrician's Award for the Best Vaccine Company. All these new categories assume great importance and relevance in the current Indian healthcare scenario,” added Mr. Sinha.
The Award process was launched in May, with nominations invited from healthcare companies across India. Frost & Sullivan followed a rigorous methodology to shortlist and select companies making a difference in the healthcare industry in India. A detailed evaluation of each shortlisted company was carried out on the basis of actual market performance indicators, which were measured on pre-decided parameters.
Some variations on specific measurements may apply to certain categories. These findings were then presented to esteemed jury members, comprising leading doctors, technologists, CEOs, and investors, who arrived on the most deserving companies in each category.
The Media Partners supporting this edition of the Awards were BioSpectrum India, Healthcare Executive, Healthcare Radius, LifeScience India, Medical Buyer, Modern Medicare, Pharma Focus Asia, Pharmaceutical-tech.com, Pharma Bio World, Pharma Quest, and The Pharma Review.
The Champions of 2012 are:
|Award Titles and Categories ||Award Recipients |
|Lifetime Achievement Award ||Dr. Habil Khorakiwala, Chairman - Wockhardt Limited |
|Healthcare Delivery Services |
|Healthcare Service Provider Company of the Year (Revenue above INR 1000 Cr.) ||Apollo Hospitals Enterprises Limited |
|Healthcare Service Provider Company of the Year (Revenue between INR 500-1000 Cr.) ||Narayana Hrudayalaya Pvt. Limited |
|Healthcare Service Provider Company of the Year (Revenue less than INR 500Cr.) ||Global Hospitals Pvt. Limited |
|Dental Care Service Provider Company of the Year ||Axiss Dental Pvt. Limited |
|Dialysis Service Provider Company of the Year ||B Braun India Limited |
|Eye Care Service Provider Company of the Year ||Eye-Q Vision Pvt. Limited |
|Diagnostic Service Provider Company of the Year ||Dr Lal Path Labs Pvt. Limited |
|Alternative Medicine & Wellness Service Provider Company of the Year ||Dr. Batra's Positive Health Clinic Pvt. Limited |
|Healthcare IT |
|m-Health Initiative of the Year ||iKure Techsoft Pvt Limited |
|EMR Company of the Year ||Aavanor Systems Pvt Limited |
|Medical Technologies |
|Wound Management Company of the Year ||3M Healthcare |
|Ophthalmic Implants Company of the Year ||Appasamy Associates |
|Imaging Equipment Company of the Year ||Siemens Healthcare |
|Sleep Solutions Company of the Year ||Philips Healthcare |
|In Vitro Diagnostics Company of the Year ||Roche Diagnostics India Pvt. Limited |
|Sterilization Management Company of The Year ||Getinge India Pvt. Limited |
|Cardiology Treatment Company of the Year ||Philips Healthcare |
|MNC Pharmaceutical Company of the Year ||Abbott India Limited |
|Indian Clinical Research Organization of the Year ||Siro Clinpharm Pvt. Limited |
|Fastest-Growing Indian International Pharmaceutical Company of the Year ||Sun Pharmaceutical Industries Limited |
|Fastest-Growing Indian Biotechnology Company of the Year ||Bharat Serums and Vaccines Limited |
|Oncologist's Award for the Best Oncology Company of the Year ||Roche India Limited |
|Diabetologist's Award for the Best Diabetology Company of the Year ||Novo Nordisk India Pvt. Limited |
|Paediatrician's Award for the Best Vaccine Company of the Year ||GlaxoSmithKline Pharmaceuticals Limited |
|Decision Time! The Jury that will decide the Award Recipients of Frost & Sulliva's 4th Annual India Healthcare Excellence Awards 2012 |
Mumbai, India, 31 August 2012 – Frost & Sullivan’s 4th Annual India Healthcare Excellence Awards 2012 is scheduled to be held on September 21, 2012 at J W Marriott, Mumbai. As the clock ticks towards the final day, Frost & Sullivan announces the distinguished Jury that will chair this year’s edition and decide on the final movers and shakers of the healthcare industry.
Frost & Sullivan follows a rigorous methodology in shortlisting and thereafter selecting companies making a difference to the healthcare industry in India. A detailed evaluation of each shortlisted company is carried out based on actual market performance indicators that are measured on parameters given below. Some variations on specific measurements may apply to certain categories. Base year for benchmark study is financial year 2011-2012.
- Revenue and market share growth
- Proof of success in executing a restructuring strategy
- Geographical and product/service line expansions
- Marketing, promotion, and visibility of the company
- Value-added services
- Evidence of success through strategy innovation and acquisitions
- Technological innovation and clinical excellence
- Increased name recognition through awards and accreditation
Based on the thorough research conducted by Frost & Sullivan in shortlisting companies, followed by the extensive industry experience and insight brought in by the jury members, the recipients for the ‘Frost & Sullivan 4th Annual India Healthcare Excellence Awards 2012’ will be selected.
The esteemed Jury for Frost & Sullivan 4th Annual India Healthcare Excellence Awards 2012 are:
- Mr. Annaswamy Vaidheesh, Vice President Government Affairs, Asia-Pacific, Johnson & Johnson, US
- Mr. B S Bedi, President, Telemedicine Society of India and Advisor at Media Lab Asia & CDAC, Delhi
- Dr. Bhavin Jankharia, President and Consultant Radiologist, SRL Diagnostics - Jankharia Imaging, Mumbai
- Mr. D G Shah, Secretary-General of the Indian Pharmaceutical Alliance, Co-Chairman of the FICCI's Committee on Pharmaceuticals, Mumbai
- Mr. Gaurav Malhotra, Managing Director and Chief Executive Officer, Patni Healthcare, Mumbai
- Dr. Jamshed Dalal, Director - Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai
- Dr. K Ganapathy, Senior Consultant Neurosurgeon, Apollo Hospitals and President, Apollo Telemedicine Networking Foundation, Chennai
- Dr. Nilesh Shah, Chairman and Managing Director, NM Medical, Mumbai
- Mr. Nitin Deshmukh, Founding Member and Chief Executive Officer, Kotak Private Equity, Mumbai
- Dr. Pankaj Patel, Vascular Surgeon, Mumbai
- Dr. Prafulla Kerkar, Professor and Head, Department of Cardiology, King Edward VII Memorial Hospital and Seth G.S. Medical College, Mumbai
- Dr. Preeti Devnani, Head, Sleep Disorders Clinic, Department of Neurology, Jaslok Hospital and Research Center, Mumbai
- Dr. PV Appaji, Director General and Chief Executive Officer, Pharmexil, Hyderabad
- Mr. R Basil, Co-Founder and Chief Executive Officer, Lily White Healthcare Consortium Private Limited, Bangalore
- Prof. S K Sarin, Senior Professor and Head, Department of Hepatology and Director, Institute of Liver and Biliary Sciences, Delhi
- Dr. Sujay S Prasad, Consultant Pathologist and Director, Anand Diagnostics Laboratory, Bangalore
- Mr. Suresh N, Group Editor and Senior VP, BioSpectrum, Bangalore
- Mr. Vamesh Chovatia, Managing Director, NEA Enterprise Associate India Pvt. Ltd, Mumbai
Announcing the Jury, Sandeep Sinha, Director, Healthcare & Life Sciences Practice, Frost & Sullivan, South Asia and Middle East, said, “This year again we have on-board very experienced and leading professionals from the healthcare and life sciences industry to help us through this critical and difficult task. The respected jury members are leading doctors, technologist, CEOs and investors. We have received an overwhelming response from the industry and our team is analyzing close to 150 companies across all categories; we look forward to having another successful year of Frost & Sullivan Healthcare Awards.”
The two Special Awards along with twenty-two Award titles that would be recognized at the Frost & Sullivan India Healthcare Excellence Awards 2012 are:
Lifetime Achievement Award
Healthcare Entrepreneur of the Year
Healthcare Delivery Services
Dental Care Service Provider Company of the Year
Dialysis Service Provider Company of the Year
Eye Care Service Provider Company of the Year
Diagnostic Service Provider Company of the Year
Wellness Service Provider Company of the Year
Healthcare Service Provider Company of the Year above 1000 Cr.
Healthcare Service Provider Company of the Year between 500-1000 Cr.
Healthcare Service Provider Company of the less than 500Cr.
mHealth Initiative of the Year
Electronic Medical Record (EMR) Company of the Year
Wound Management Company of the Year
Ophthalmic Implants Company of the Year
Imaging Equipment Company of the Year
Sleep Solutions Company of the Year
In Vitro Diagnostics Company of the Year
Sterilization Management Company of the Year
Cardiology Treatment Company of the Year
MNC Pharmaceutical Company of the Year
Indian Clinical Research Organisation of the Year
Fastest-Growing Indian International Pharmaceutical Company of the Year
Fastest-Growing Indian Biotechnology Company of the Year
Oncologist's Award for the Best Oncology Company of the Year
Diabetologist's Award for the Best Diabetology Company of the Year
Paediatrician's Award for the Best Vaccine Company of the Year
BioSpectrum India, Healthcare Executive, LifeScience India Medical Buyer, Modern Medicare, Pharma Focus Asia, Pharmaceutical-tech.com, PharmabioWorld, Pharma Quest and The Pharma Review are the media partners for this edition of India Healthcare Excellence Awards 2012.
To know more about the awards, please log on to www.frost.com/hcawards2012
|Frost & Sullivan to Recognize the Industry Once Again at India Healthcare Excellence Awards 2012 |
Nominations Open! Last Date for Entry: 21 June 2012
Mumbai, India, 4 May 2012 – The size of the Indian healthcare market is abysmally small when compared with similar and dissimilar economies. The per capita spend on healthcare in India is three times lower than China and 150 times lower than the United States of America. Our healthcare model ranks very low on certain parameters, namely health expenditure as percentage of GDP, per capita spending on healthcare, doctor–population and hospital bed-population ratio and infant and maternal mortality ratio. Analysis reveals that the existing system is heavily skewed in favor of the urban population. This has led to a peculiar situation with the majority of health services being centralized in urban areas where only 22-25 percent of the population resides.
The key challenges faced by industry players are, how to increase insurance penetration and introduce insurance products for the lower income group population; how to address or design product or services for the majority of population that resides in rural areas. Moreover, what should be the business models for such products and services that not only are cost effective but also sustainable and scalable?
According to Sandeep Sinha, Director, Healthcare Practice, Frost & Sullivan, “Despite these challenges, the Indian Healthcare industry is in a steady growth trajectory phase and should grow at a CAGR of 10-12 percent over the next five years. What makes this growth unique are the concurrent efforts in development of infrastructure; creation of demand for higher levels of healthcare and rising awareness of end users coupled with the aggressive launch of innovative insurance and reimbursement and financing policies to complete the circle of the end user, payer and provider value chain. The key stakeholders of the industry are responsible for this growth.”
The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Medical technology industry also has been growing at a healthy pace of 16-18 percent Y-o-Y; a few sectors like cardiology are growing at a very high pace of 35-40 percent. Advancements in medical technologies like minimally invasive surgeries, next generation stents, home health, tele-health services among others propel this growth.
Frost & Sullivan, in its effort and its commitment to recognize the innovative growth strategies and solutions adopted by the best companies in the healthcare industry, after the grand success of India Healthcare Excellence Awards 2011, announces the ‘Frost & Sullivan India Healthcare Excellence Awards 2012’ scheduled for 21st September, in Mumbai. Over the years, this Award Program has become an industry benchmark. This is due to the recognition it brings to the companies that play an important role in putting the Indian healthcare industry on the global map.
The 21 Award titles that would be recognized at the Frost & Sullivan India Healthcare Excellence Awards 2012 are:
- mHealth Initiative of the Year
- EMR Company of the Year
- Pharmaceutical Company of the Year
- Fastest growing Indian International Pharmaceutical Company of the Year
- Fastest Growing Biotechnology Company of the Year
- Oncology Company of the Year
- Diabetology Company of the Year
- Vaccine Company of the Year
- Ophthalmic Implants Company of the Year
- Imaging Equipment Company of the Year
- Sleep Solutions Company of the Year
- In-vitro Diagnostics Company of the Year
- Sterilization Equipment Company of the Year
- Cardiology Treatment Company of the Year
Healthcare Delivery Services
- Dental Care Service Provider Company of the Year
- Dialysis Service Provider Company of the Year
- Eye Care Service Provider Company of the Year
- Diagnostic Service Provider Company of the Year
- Wellness Service Provider Company of the Year
- Healthcare Retail Company of the Year
- Lifetime Achievement Award
Nominations close on 21 June 2012. If you wish to know more about the awards, contact Caroline Lewis/Nimisha Iyer at email@example.comfirstname.lastname@example.org. To send in your nominations, email email@example.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. On receipt of the above information, our team will get in touch with you with the details.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Propositionprovides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation, and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices, as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000 emerging businesses, the public sector, and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics, and emerging economies?
Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Corporate Communications – South Asia
Phone: +91.98217 37935
Fax: +91.22.2832 4713
Corporate Communications – South Asia
Phone: +91.22.6607 2020
Fax: +91.22.2832 4713
Corporate Communications – South Asia, Middle East and North Africa
Phone: +91 98200 50519
Fax: +91 22 2832 4713